Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,832 | 36,810 | 30,159 | 35,627 | 33,184 |
| Marketable Securities | 79,777 | 106,559 | 118,989 | 135,930 | 167,159 |
| TOTAL | $132,153 | $148,404 | $154,947 | $178,306 | $207,632 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 89 |
| Investments And Advances | 9,443 | 22,797 | 48,795 | 59,968 | 58,552 |
| Other Non-Current Assets | 625 | 696 | 736 | 718 | 702 |
| TOTAL | $10,068 | $23,493 | $49,531 | $60,686 | $59,343 |
| Total Assets | $142,221 | $171,897 | $204,478 | $238,992 | $266,975 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,598 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 682 | 2,103 | 1,056 | 5,648 | 2,342 |
| Accrued Expenses | 17,676 | 22,758 | 18,259 | 21,959 | 17,443 |
| TOTAL | $21,956 | $24,861 | $19,315 | $27,607 | $19,914 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,053 | 29,882 | 29,528 | 29,419 | 29,674 |
| Other Non-Current Liabilities | 39 | 77 | 114 | 150 | 185 |
| TOTAL | $27,092 | $29,959 | $29,642 | $29,569 | $29,859 |
| Total Liabilities | $49,048 | $54,820 | $48,957 | $57,176 | $49,773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,573 | 60,573 | 60,573 | 60,573 | 60,080 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -421,324 | -394,873 | -353,923 | -325,127 | -287,973 |
| Other shareholders' equity | 109 | 23 | 15 | -48 | 518 |
| TOTAL | $93,173 | $117,077 | $155,521 | $181,816 | $217,202 |
| Total Liabilities And Equity | $142,221 | $171,897 | $204,478 | $238,992 | $266,975 |